H

Hanall Biopharma
A009420

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
₩1.23T
EV
₩1.22T
Shares Outstanding
50.74M
Beta
0.77

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
₩43833.33
P/E 2025E
194.05x
P/Revenue 2025E
7.95x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Hanall Biopharma Co., Ltd.

gainify

H

Hanall Biopharma Co., Ltd.

A009420

Hanall Biopharma Co., Ltd., a pharmaceutical company, manufactures and sells pharmaceutical products in South Korea and internationally. The company offers prescription drugs and over-the-counter products for the treatment of diarrhea, prostatic hyperplasia, androgene...

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Data Unavailable

Employees

304

IPO Date

2000-01-04

Headquarters

43, Sangseodang 1-gil, Daedeok-gu, Daejeon South Korea

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

COMPANY

Pricing

Dashboard

About Us

Contact Us

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.